Overview
- Authorities apprehended Khalid Ahmed Satary overseas and transferred him to U.S. custody after a July 20, 2026 arrest, and he made an initial federal court appearance the next day.
- Satary is accused in a 2019 indictment of running diagnostic labs that billed Medicare about $547 million for expensive, medically unnecessary genetic tests from 2016 to 2019.
- Prosecutors allege the scheme used telemarketing call centers, patient recruiters, telemedicine doctors, and illegal kickbacks to generate test orders that reimbursed roughly $10,000 to $20,000 per sample.
- After his 2019 indictment Satary was released on bond with a ban on health‑care work, prosecutors say he violated those terms, a warrant issued when he failed to appear in 2022, and he lived as a fugitive until this capture.
- The Justice Department and FBI say the arrest—part of the new Most Wanted Fraudsters initiative—follows prior seizures of 16 bank accounts and restrained real estate and could lead to further asset recovery and prosecutions in the broader health‑care fraud enforcement effort.